{"symbol": "NVUS", "companyName": "Novus Therapeutics Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.novustherapeutics.com", "description": "Novus Therapeutics Inc is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat products. Its technologies have the potential to be developed for multiple ENT indications.", "CEO": "Gregory J. Flesher", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}